Dana-Farber Cancer Institute, Inc`s Profile
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of Dana-Farber Cancer Institute, Inc look like?
|Grant Index||40.0 %|
|Abandoned/Rejected Applications:||3 (60.0%)|
|Average Grant Time:||4.34 Years|
|Average Office Actions:||3.5|
Which Technology Area Dana-Farber Cancer Institute, Inc is filing most patents in? (Last 10 years)
|Art Unit||Definition||Total Applications|
|1613||Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs||3|
|1634||Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry||1|
|1642||Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology||1|
|1644||Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology||1|
How many patents are Dana-Farber Cancer Institute, Inc filing every year?
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of Dana-Farber Cancer Institute, Inc in USPTO?
How are Dana-Farber Cancer Institute, Inc’s applications performing in USPTO?
|Application Number||Title||Status||Art Unit||Examiner|